Fernandez Henry A
SEC CIK 1416750 · EDGAR
BoughtSold
Most active insiders at MSCI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fernandez Henry A | COB, CEO, Dir | $12.51M | — |
| 2 | Munari Alvise J. | Chief Product Off | — | $5.92M |
| 3 | Ashe Robert G. | Dir | $2.00M | — |
| 4 | Taneja Rajat | Dir | $1.00M | — |
| 5 | Wiechmann Andrew C. | CFO | — | $771.6K |
| 6 | Gutowski Robert J. | GC | — | $348.5K |
| 7 | Yang June | Dir | — | — |
| 8 | Seitz Michelle | Dir | — | — |
| 9 | Volent Paula | Dir | — | — |
| 10 | Rattray Sandy C. | Dir | — | — |
Transactions 43
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-18 16:10 | 2026-05-15 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $562.40 | +4,000 | 1.73M | +0.2% | +$2.25M |
| MI | 2026-04-30 16:05 | 2026-04-28 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | G - Gift | $0.00 | 0 | 410.8K | New | $0 |
| M | 2026-02-17 | 2026-02-13+ | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $523.56 | +6,800 | 1.49M | +0.5% | +$3.56M |
| M | 2025-12-09 | 2025-12-05 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $536.13 | +10.2K | 1.48M | +0.7% | +$5.47M |
| MI | 2025-12-09 | 2025-12-05 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $536.17 | +2,290 | 335.1K | +0.7% | +$1.23M |
| M | 2025-07-28 | 2025-07-24+ | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $544.73 | +10.0K | 1.28M | +0.8% | +$5.45M |
| I | 2025-07-28 | 2025-07-24 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $535.11 | +2,400 | 332.8K | +0.7% | +$1.28M |
| 2025-06-30 | 2025-06-30 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $35.24 | +1,064 | 65.3K | +2% | +$37.5K | |
| 2025-05-14 | 2025-05-13 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $0.00 | +7,614 | 64.3K | +13% | $0 | |
| 2025-04-01 | 2025-03-31 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $32.87 | +1,141 | 56.6K | +2% | +$37.5K | |
| M | 2025-02-25 | 2025-02-24 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $574.51 | +5,300 | 1.27M | +0.4% | +$3.04M |
| 2025-02-10 | 2025-02-06 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | F - Tax | $587.48 | -32.3K | 1.26M | -2% | -$18.96M | |
| 2025-02-10 | 2025-02-06 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | A - Grant | $0.00 | +58.4K | 1.30M | +5% | $0 | |
| 2025-01-02 | 2024-12-31 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $24.94 | +1,503 | 55.5K | +3% | +$37.5K | |
| MI | 2024-12-09 | 2024-12-05 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $612.80 | +2,900 | 328.1K | +0.9% | +$1.78M |
| 2024-09-30 | 2024-09-30 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $27.92 | +1,342 | 54.0K | +3% | +$37.5K | |
| 2024-06-28 | 2024-06-28 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $26.80 | +1,399 | 52.7K | +3% | +$37.5K | |
| 2024-06-10 | 2024-06-07 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $0.00 | +9,293 | 51.3K | +22% | $0 | |
| MI | 2024-04-26 | 2024-04-25 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | P - Purchase | $465.92 | +13.0K | 315.9K | +4% | +$6.06M |
| M | 2024-04-26 | 2024-04-25 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | G - Gift | $0.00 | -22.5K | 1.75M | -1% | $0 |
| MI | 2024-04-26 | 2024-04-25 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | G - Gift | $0.00 | +22.5K | 15.4K | New | $0 |
| 2024-04-02 | 2024-03-28 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $30.23 | +1,240 | 42.0K | +3% | +$37.5K | |
| M | 2024-02-07 | 2024-02-05 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | F - Tax | $583.39 | -50.5K | 1.52M | -3% | -$29.46M |
| M | 2024-02-07 | 2024-02-05 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | A - Grant | $0.00 | +91.3K | 1.56M | +6% | $0 |
| 2023-12-29 | 2023-12-29 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $27.71 | +1,353 | 40.7K | +3% | +$37.5K | |
| 2023-10-03 | 2023-09-29 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $27.08 | +1,384 | 39.4K | +4% | +$37.5K | |
| 2023-06-30 | 2023-06-30 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $31.03 | +1,208 | 38.0K | +3% | +$37.5K | |
| 2023-06-26 | 2023-06-23 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $0.00 | +7,747 | 36.8K | +27% | $0 | |
| 2023-03-31 | 2023-03-31 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $35.73 | +1,049 | 29.0K | +4% | +$37.5K | |
| 2023-02-10 | 2023-02-08 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | A - Grant | $0.00 | +28.5K | 1.24M | +2% | $0 | |
| 2023-02-10 | 2023-02-08 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | F - Tax | $556.90 | -15.7K | 1.22M | -1% | -$8.77M | |
| 2023-01-03 | 2022-12-30 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $39.76 | +943 | 28.0K | +3% | +$37.5K | |
| 2022-09-30 | 2022-09-30 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $41.06 | +913 | 27.0K | +3% | +$37.5K | |
| 2022-06-30 | 2022-06-30 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $41.52 | +903 | 26.1K | +4% | +$37.5K | |
| 2022-06-24 | 2022-06-24 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $0.00 | +6,328 | 25.2K | +33% | $0 | |
| 2022-04-01 | 2022-03-31 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $38.87 | +964 | 18.9K | +5% | +$37.5K | |
| I | 2022-02-25 | 2022-02-24 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | P - Purchase | $37.49 | +32.5K | 58.2K | +126% | +$1.22M |
| M | 2022-02-09 | 2021-12-21 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | G - Gift | $0.00 | -11.4K | 1.68M | -0.7% | $0 |
| MI | 2022-02-09 | 2021-12-21 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | G - Gift | $0.00 | +11.4K | 7,900 | New | $0 |
| 2022-02-09 | 2022-02-07 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | F - Tax | $550.45 | -42.5K | 1.21M | -3% | -$23.37M | |
| 2022-02-09 | 2022-02-07 | MSCI | MSCI | Fernandez Henry A | COB, CEO, Dir | A - Grant | $0.00 | +80.2K | 1.25M | +7% | $0 | |
| 2022-01-03 | 2021-12-31 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $39.11 | +958 | 17.9K | +6% | +$37.5K | |
| 2021-09-30 | 2021-09-30 | RPRX | Royalty Pharma plc | Fernandez Henry A | Dir | A - Grant | $37.80 | +992 | 17.0K | +6% | +$37.5K |
Purchase Sale Sale after option exercise All abbreviations